Wu Y C, Cai Y L, Rong L, Zhang J X, Liu J, Wang X
Department of General Surgery, Peking University First Hospital, Beijing 100034, China.
Department of Endoscopy, Peking University First Hospital, Beijing 100034, China.
Beijing Da Xue Xue Bao Yi Xue Ban. 2020 Dec 18;52(6):1093-1097. doi: 10.19723/j.issn.1671-167X.2020.06.017.
To investigate the correlation between clinicopathological features and lymph node metastasis, and to evaluate the feasibility and efficacy of endoscopic submucosal dissection (ESD) in early gastric cancer (EGC) by comparing with surgery treatment.
The clinicopathological data of 320 patients with EGC who were treated in Peking University First Hospital between January 2010 and December 2017 were retrospectively reviewed, in which there were 198 cases of surgical procedure and 122 cases of ESD. Characteristics of lymph node metastasis in EGC were analyzed, and lymph node metastasis of EGC with ESD absolute and expanded indications were summarized. The long-term efficacy of ESD and surgical treatment of EGC were compared to evaluate the rationality of absolute and expanded indications of ESD.
Lymph node metastasis was detected in 22 (11.1%) of 198 patients. Univariate analysis showed a positive relationship between tumor size (=5.525, =0.019), depth of invasion(=8.235, =0.004), histological type (=6.323, =0.012), lymphovascular invasion (=12.273, < 0.001) and lymph node metastasis in EGC. Multivariate analysis revealed that depth of invasion(=7.575, =0.006) and histological type (=6.317, =0.012) were independent relative factors of lymph node metastasis in EGC. The lymph node metastasis rates of the patients with absolute and expanded ESD indications were both 0%. The 5-year survival rates of the patients who met ESD absolute indication receiving surgery treatment and ESD were 97.6% and 97.9% respectively, and the difference between the two groups was not statistically significant(=0.014, =0.907).The 5-year survival rates of the patients who met ESD expanded indication receiving surgery treatment and ESD were 96.5% and 91.7% respectively, the difference between the two groups was not statistically significant(=1.061, =0.303).
Lymph node metastasis in EGC is mainly correlated with depth of invasion and histological type. Our data indicate that ESD procedure for EGC is comparable to surgery in terms of long-term efficacy in both absolute and expanded indications. However, some studies of a large sample size are still needed for more confirmation.
探讨早期胃癌(EGC)临床病理特征与淋巴结转移的相关性,并通过与手术治疗对比,评估内镜黏膜下剥离术(ESD)治疗EGC的可行性及疗效。
回顾性分析2010年1月至2017年12月于北京大学第一医院接受治疗的320例EGC患者的临床病理资料,其中198例行手术治疗,122例行ESD。分析EGC患者淋巴结转移特征,总结ESD绝对适应证和扩大适应证EGC患者的淋巴结转移情况。比较ESD与手术治疗EGC的长期疗效,评估ESD绝对适应证和扩大适应证的合理性。
198例患者中22例(11.1%)检测到淋巴结转移。单因素分析显示,肿瘤大小(=5.525,=0.019)、浸润深度(=8.235,=0.004)、组织学类型(=6.323,=0.012)、淋巴管浸润(=12.273,<0.001)与EGC患者淋巴结转移呈正相关。多因素分析显示,浸润深度(=7.575,=0.006)和组织学类型(=6.317,=0.012)是EGC患者淋巴结转移的独立相关因素。ESD绝对适应证和扩大适应证患者的淋巴结转移率均为0%。符合ESD绝对适应证接受手术治疗和ESD患者的5年生存率分别为97.6%和97.9%,两组差异无统计学意义(=0.014,=0.907)。符合ESD扩大适应证接受手术治疗和ESD患者的5年生存率分别为96.5%和91.7%,两组差异无统计学意义(=1.061,=0.303)。
EGC患者淋巴结转移主要与浸润深度和组织学类型相关。我们的数据表明,ESD治疗EGC在绝对适应证和扩大适应证方面的长期疗效与手术相当。然而,仍需要更多大样本研究进行进一步证实。